Ahonen, Iida
Laurikka, Pilvi
Koskimaa, Sara
Huhtala, Heini
Lindfors, Katri
Kaukinen, Katri
Kurppa, Kalle
Kivelä, Laura
Funding for this research was provided by:
Emil Aaltonen Foundation
Finnish Coeliac Society
Sigrid Juselius Foundation
Academy of Finland (339183 and 347473, 339183 and 347473)
Competitive State Research Financing of the Expert Area of Tampere University Hospital
Finnish Cultural Foundation
Foundation for Pediatric Research
Päivikki and Sakari Sohlberg Foundation
Paulo Foundation
Tampere University including Tampere University Hospital, Tampere University of Applied Sciences
Article History
Received: 6 June 2023
Accepted: 25 August 2023
First Online: 6 September 2023
Declarations
:
: The study was approved by the Ethics Committee of the Pirkanmaa Hospital District. All methods were performed in accordance with the Declaration of Helsinki. All study patients gave written informed consent and were aware of their opportunity to withdraw their consent to participate at any time without explanation.
: Not applicable.
: Laura Kivelä, Pilvi Laurikka, and Kalle Kurppa have received personal lecture fees from the Finnish Coeliac Society outside the submitted work and Laura Kivelä, Pilvi Laurikka, Katri Kaukinen, Katri Lindfors and Kalle Kurppa serve as members of the advisory committee of the Finnish Coeliac Society. Kalle Kurppa is a board member of the International Society for the Study of Celiac Disease and Katri Lindfors of the Multisociety Celiac Disease Consortium. Kalle Kurppa and Pilvi Laurikka have received personal lecture fees from Thermo Fisher Scientific outside the work submitted here. The other authors report no conflict of interest.